Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.

Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M, Soonpaa MH, de la Rivière AB, Doevendans PA, Field LJ.

Cardiovasc Res. 2008 Apr 1;78(1):18-25. Epub 2007 Dec 12.

2.

Divide to survive: myocardial regeneration and functional recovery after cell cycle activation in injured hearts.

Costa AD.

Cardiovasc Res. 2008 Apr 1;78(1):1-2. doi: 10.1093/cvr/cvn026. Epub 2008 Feb 4. No abstract available.

3.

Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes.

Zaruba MM, Zhu W, Soonpaa MH, Reuter S, Franz WM, Field LJ.

Eur Heart J. 2012 Jan;33(1):129-37. doi: 10.1093/eurheartj/ehr302. Epub 2011 Aug 17.

4.

Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.

Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ.

Circ Res. 2005 Jan 7;96(1):110-8. Epub 2004 Dec 2.

5.

Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.

Li L, Zeng H, Chen JX.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H605-18. doi: 10.1152/ajpheart.00366.2012. Epub 2012 Jun 29.

6.

Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.

Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD.

Circ Res. 2004 May 14;94(9):1256-62. Epub 2004 Mar 25.

7.

Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model.

Lin Z, von Gise A, Zhou P, Gu F, Ma Q, Jiang J, Yau AL, Buck JN, Gouin KA, van Gorp PR, Zhou B, Chen J, Seidman JG, Wang DZ, Pu WT.

Circ Res. 2014 Jul 18;115(3):354-63. doi: 10.1161/CIRCRESAHA.115.303632. Epub 2014 May 15.

8.

Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs.

Zhang LX, DeNicola M, Qin X, Du J, Ma J, Tina Zhao Y, Zhuang S, Liu PY, Wei L, Qin G, Tang Y, Zhao TC.

Am J Physiol Cell Physiol. 2014 Aug 15;307(4):C358-72. doi: 10.1152/ajpcell.00187.2013. Epub 2014 Jun 18.

9.

Complete cardiac regeneration in a mouse model of myocardial infarction.

Haubner BJ, Adamowicz-Brice M, Khadayate S, Tiefenthaler V, Metzler B, Aitman T, Penninger JM.

Aging (Albany NY). 2012 Dec;4(12):966-77.

10.

Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.

Xiang FL, Lu X, Hammoud L, Zhu P, Chidiac P, Robbins J, Feng Q.

Circulation. 2009 Sep 22;120(12):1065-74, 9 p following 1074. doi: 10.1161/CIRCULATIONAHA.108.839068. Epub 2009 Sep 8.

11.

Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.

Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, Ikeda U.

Circ Res. 2006 Oct 13;99(8):891-9. Epub 2006 Sep 21.

12.

Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium.

Smits AM, van Laake LW, den Ouden K, Schreurs C, Szuhai K, van Echteld CJ, Mummery CL, Doevendans PA, Goumans MJ.

Cardiovasc Res. 2009 Aug 1;83(3):527-35. doi: 10.1093/cvr/cvp146. Epub 2009 May 9.

13.

High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.

Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, Ishino M, Bilim O, Nakajima O, Kubota I.

Cardiovasc Res. 2008 Oct 1;80(1):40-6. doi: 10.1093/cvr/cvn163. Epub 2008 Jun 16.

14.

Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.

Woulfe KC, Gao E, Lal H, Harris D, Fan Q, Vagnozzi R, DeCaul M, Shang X, Patel S, Woodgett JR, Force T, Zhou J.

Circ Res. 2010 May 28;106(10):1635-45. doi: 10.1161/CIRCRESAHA.109.211482. Epub 2010 Apr 1.

15.

Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.

Ahmad F, Lal H, Zhou J, Vagnozzi RJ, Yu JE, Shang X, Woodgett JR, Gao E, Force T.

J Am Coll Cardiol. 2014 Aug 19;64(7):696-706. doi: 10.1016/j.jacc.2014.04.068.

16.

Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.

Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH, Yang Q, Huang Y, Wei YS, Liu PP, Liu DP, Liang CC.

Circulation. 2007 Apr 10;115(14):1885-94. Epub 2007 Mar 26.

17.

Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase.

Tamamori-Adachi M, Takagi H, Hashimoto K, Goto K, Hidaka T, Koshimizu U, Yamada K, Goto I, Maejima Y, Isobe M, Nakayama KI, Inomata N, Kitajima S.

Cardiovasc Res. 2008 Nov 1;80(2):181-90. doi: 10.1093/cvr/cvn183. Epub 2008 Jul 2.

18.

Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.

Niizeki T, Takeishi Y, Arimoto T, Takahashi H, Shishido T, Koyama Y, Goto K, Walsh RA, Kubota I.

Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1105-12. Epub 2006 Oct 27.

19.

Cardiac-specific overexpression of human stem cell factor promotes epicardial activation and arteriogenesis after myocardial infarction.

Xiang FL, Liu Y, Lu X, Jones DL, Feng Q.

Circ Heart Fail. 2014 Sep;7(5):831-42. doi: 10.1161/CIRCHEARTFAILURE.114.001423. Epub 2014 Aug 8.

20.

Cell-cycle-based strategies to drive myocardial repair.

Zhu W, Hassink RJ, Rubart M, Field LJ.

Pediatr Cardiol. 2009 Jul;30(5):710-5. doi: 10.1007/s00246-009-9408-3. Epub 2009 Apr 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk